Insider Trading activities at Seagen Inc. (SGEN) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seagen Inc. (SGEN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seagen Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1060736.

Total stock buying since 2014: $1,160,479,679.
Total stock sales since 2014: $1,004,689,522.
Total stock option exercises since 2014: $71,753,696.


 1   2   3   4 
22 insiders reported insider trading activities at Seagen Inc. (SGEN):
Insider trading activities of 14159, L.p.
Insider trading activities of Baker Felix
Insider trading activities of Lippman Marc E
Insider trading activities of Romp Charles R
Insider trading activities of Welch Daniel G
Insider trading activities of Baker Bros. Advisors (gp) Llc
Insider trading activities of Boerner Christopher S.
Insider trading activities of Epstein David R
Insider trading activities of Akkaraju Srinivas
Insider trading activities of Baker Julian
Insider trading activities of Dansey Roger D
Insider trading activities of Simonian Nancy A
Insider trading activities of Drachman Jonathan G
Insider trading activities of Siegall Clay B
Insider trading activities of Dobmeier Eric
Insider trading activities of Liu Jean I
Insider trading activities of Himes Vaughn B
Insider trading activities of Gryska David W
Insider trading activities of Baker Brothers Life Sciences Lp
Insider trading activities of Orwin John A
Insider trading activities of Cline Darren S
Insider trading activities of Simpson Todd E

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Seagen Inc. (SGEN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2023 0 $0 392,914 $73,193,732 322,898 $16,265,420
2022 0 $0 250,716 $37,014,358 234,844 $7,144,665
2021 0 $0 968,655 $156,502,918 465,023 $11,080,930
2020 0 $0 3,776,313 $607,190,520 685,142 $14,851,091
2019 0 $0 532,740 $44,228,990 430,833 $6,089,430
2018 5,306,804 $275,895,222 375,703 $24,277,576 373,126 $4,469,898
2017 0 $0 425,707 $24,086,518 375,862 $4,731,181
2016 6,200,638 $257,974,072 373,779 $18,628,401 407,265 $4,207,373
2015 9,422,008 $389,855,263 381,027 $15,900,526 277,285 $2,245,552
2014 7,019,620 $236,755,122 89,351 $3,665,983 86,333 $668,156


Table 3. Detailed insider trading at Seagen Inc. (SGEN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-03-09 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2020-03-06 Himes Vaughn B (Chief Technical Officer) Sale 8,000 115.31 922,504
2020-03-06 Himes Vaughn B (Chief Technical Officer) Option Ex 8,000 13.73 109,840
2020-02-18 Dansey Roger D (Chief Medical Officer) Sale 350 116.33 40,715
2020-02-10 Siegall Clay B (President and CEO) Sale 28,472 114.86 3,270,208
2020-02-10 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2020-02-03 Dansey Roger D (Chief Medical Officer) Sale 727 108.51 78,886
2020-01-08 Siegall Clay B (President and CEO) Sale 28,472 111.69 3,179,895
2020-01-08 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2020-01-07 Welch Daniel G (Director) Option Ex 17,500 12.76 223,300
2019-12-16 Dansey Roger D (Chief Medical Officer) Sale 2,000 114.07 228,140
2019-12-09 Siegall Clay B (President and CEO) Sale 28,472 115.79 3,296,715
2019-12-09 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2019-12-06 Himes Vaughn B (Chief Technical Officer) Sale 8,000 117.35 938,800
2019-12-06 Himes Vaughn B (Chief Technical Officer) Option Ex 8,000 12.00 96,000
2019-11-25 Dansey Roger D (Chief Medical Officer) Sale 5,000 121.48 607,390
2019-11-25 Dansey Roger D (Chief Medical Officer) Option Ex 5,000 65.11 325,550
2019-11-21 Akkaraju Srinivas (Director) Sale 17,500 119.98 2,099,737
2019-11-21 Akkaraju Srinivas (Director) Option Ex 17,500 19.02 332,850
2019-11-18 Dansey Roger D (Chief Medical Officer) Sale 5,000 116.00 580,000
2019-11-18 Dansey Roger D (Chief Medical Officer) Option Ex 5,000 65.11 325,550
2019-11-18 Lippman Marc E (Director) Sale 35,000 115.80 4,053,000
2019-11-18 Lippman Marc E (Director) Option Ex 35,000 15.89 556,150
2019-11-08 Siegall Clay B (President and CEO) Sale 28,472 106.43 3,030,218
2019-11-08 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2019-10-08 Siegall Clay B (President and CEO) Sale 28,472 82.93 2,361,268
2019-10-08 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2019-10-01 Gryska David W (Director) Sale 5,000 85.09 425,450
2019-10-01 Gryska David W (Director) Option Ex 5,000 15.89 79,450
2019-09-30 Liu Jean I (GC/EVP, Leg Affairs) Sale 7,432 86.00 639,152
2019-09-30 Simpson Todd E (Chief Financial Officer) Sale 15,000 85.00 1,275,000
2019-09-25 Dansey Roger D (Chief Medical Officer) Sale 3,000 73.98 221,940
2019-09-09 Siegall Clay B (President and CEO) Sale 28,472 69.41 1,976,184
2019-09-09 Siegall Clay B (President and CEO) Option Ex 28,472 12.00 341,664
2019-09-03 Dansey Roger D (See Remarks) Sale 922 70.80 65,277
2019-09-03 Himes Vaughn B (See Remarks) Sale 5,692 70.80 402,987
2019-09-03 Liu Jean I (See Remarks) Sale 1,779 .00 0
2019-09-03 Simpson Todd E (See Remarks) Sale 2,092 70.80 148,111
2019-09-03 Siegall Clay B (See Remarks) Sale 9,693 70.80 686,254
2019-08-30 Himes Vaughn B (See Remarks) Sale 8,000 73.03 584,240
2019-08-30 Himes Vaughn B (See Remarks) Option Ex 8,000 12.00 96,000
2019-08-28 Himes Vaughn B (Chief Technical Officer) Sale 6,836 73.22 500,497
2019-08-28 Liu Jean I (GC/EVP, Leg Affairs) Sale 6,013 73.22 440,241
2019-08-28 Simpson Todd E (Chief Financial Officer) Sale 5,909 73.21 432,621
2019-08-28 Siegall Clay B (President and CEO) Sale 28,951 73.22 2,119,647
2019-08-20 Liu Jean I (GC/EVP, Leg Affairs) Sale 3,716 80.00 297,280
2019-08-20 Simpson Todd E (Chief Financial Officer) Sale 12,500 80.00 1,000,000
2019-08-08 Siegall Clay B (President and CEO) Sale 20,149 76.19 1,535,152
2019-08-08 Siegall Clay B (President and CEO) Option Ex 20,149 12.16 245,011
2019-08-06 Liu Jean I (GC/EVP, Leg Affairs) Sale 3,716 75.00 278,700
2019-07-17 Gryska David W (Director) Sale 5,000 75.00 375,000
2019-07-17 Gryska David W (Director) Option Ex 5,000 12.76 63,800
2019-07-08 Siegall Clay B (President and CEO) Sale 20,148 67.50 1,359,929
2019-07-08 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2019-06-24 Himes Vaughn B (Chief Technical Officer) Option Ex 4,704 42.56 200,225
2019-06-17 Dansey Roger D (Chief Medical Officer) Sale 5,416 68.60 371,537
2019-06-10 Siegall Clay B (President and CEO) Sale 20,148 69.56 1,401,394
2019-06-10 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2019-05-31 Himes Vaughn B (Chief Technical Officer) Sale 8,000 66.08 528,680
2019-05-31 Himes Vaughn B (Chief Technical Officer) Option Ex 8,000 12.00 96,000
2019-05-09 Siegall Clay B (President and CEO) Sale 4,824 67.35 324,896
2019-05-09 Siegall Clay B (President and CEO) Option Ex 4,824 12.16 58,659
2019-05-08 Siegall Clay B (President and CEO) Sale 15,324 68.22 1,045,449
2019-05-08 Siegall Clay B (President and CEO) Option Ex 15,324 12.16 186,339
2019-04-29 Baker Julian (Director) Option Ex 20,000 8.38 167,600
2019-04-08 Siegall Clay B (President and CEO) Sale 20,148 78.94 1,590,483
2019-04-08 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2019-04-05 Simpson Todd E (Chief Financial Officer) Sale 12,500 78.00 975,000
2019-04-01 Gryska David W (Director) Sale 5,000 73.69 368,474
2019-04-01 Gryska David W (Director) Option Ex 5,000 12.76 63,800
2019-03-18 Siegall Clay B (President and CEO) Option Ex 16,556 12.08 199,996
2019-03-08 Himes Vaughn B (Chief Technical Officer) Sale 8,000 68.77 550,120
2019-03-08 Himes Vaughn B (Chief Technical Officer) Option Ex 8,000 12.00 96,000
2019-03-08 Siegall Clay B (President and CEO) Sale 20,148 69.12 1,392,730
2019-03-08 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2019-03-04 Simpson Todd E (Chief Financial Officer) Sale 10,000 75.00 750,000
2019-02-08 Siegall Clay B (See Remarks) Sale 20,148 65.72 1,324,187
2019-02-08 Siegall Clay B (See Remarks) Option Ex 20,148 12.16 244,999
2019-01-08 Gryska David W (Director) Sale 5,000 65.04 325,200
2019-01-08 Gryska David W (Director) Option Ex 5,000 12.76 63,800
2019-01-08 Siegall Clay B (President and CEO) Sale 20,148 65.61 1,321,910
2019-01-08 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2018-12-10 Siegall Clay B (President and CEO) Sale 20,148 59.96 1,208,134
2018-12-10 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2018-11-30 Himes Vaughn B (Chief Technical Officer) Sale 5,000 62.42 312,125
2018-11-30 Himes Vaughn B (Chief Technical Officer) Option Ex 5,000 12.00 60,000
2018-11-29 Cline Darren S (EVP, Commercial) Sale 7,000 62.88 440,160
2018-11-21 Cline Darren S (EVP, Commercial) Sale 4,167 56.69 236,206
2018-11-08 Siegall Clay B (President and CEO) Sale 20,148 61.66 1,242,426
2018-11-08 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2018-10-30 Akkaraju Srinivas (Director) Option Ex 5,000 8.38 41,900
2018-10-08 Siegall Clay B (President and CEO) Sale 20,148 77.27 1,556,835
2018-10-08 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2018-09-17 Siegall Clay B (President and CEO) Sale 20,148 77.19 1,555,163
2018-09-17 Siegall Clay B (President and CEO) Option Ex 20,148 12.16 244,999
2018-09-07 Himes Vaughn B (Chief Technical Officer) Sale 5,000 76.73 383,675
2018-09-07 Himes Vaughn B (Chief Technical Officer) Option Ex 5,000 12.00 60,000
2018-08-27 Cline Darren S (EVP, Commercial) Sale 4,784 74.23 355,125
2018-08-27 Himes Vaughn B (Chief Technical Officer) Sale 5,530 74.23 410,502
2018-08-27 Liu Jean I (GC/EVP, Leg Affairs) Sale 4,123 74.23 306,058
2018-08-27 Simpson Todd E (Chief Financial Officer) Sale 5,427 74.23 402,857
2018-08-27 Siegall Clay B (President and CEO) Sale 25,514 74.23 1,893,955
2018-08-21 Siegall Clay B (President and CEO) Sale 25,000 74.95 1,873,750
2018-08-09 Siegall Clay B (See Remarks) Sale 18,831 72.91 1,372,874
2018-08-09 Siegall Clay B (See Remarks) Option Ex 18,831 11.09 208,835
2018-07-31 Lippman Marc E (Director) Sale 7,400 69.25 512,450
2018-07-09 Siegall Clay B (President and CEO) Sale 18,832 69.30 1,305,057
2018-07-09 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2018-06-12 Cline Darren S (EVP, Commercial) Sale 12,054 68.99 831,581
2018-06-12 Cline Darren S (EVP, Commercial) Option Ex 10,086 22.34 225,270
2018-06-08 Siegall Clay B (President and CEO) Sale 18,832 65.37 1,231,047
2018-06-08 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2018-05-31 Himes Vaughn B (Chief Technical Officer) Sale 5,000 58.41 292,050
2018-05-31 Himes Vaughn B (Chief Technical Officer) Option Ex 5,000 12.00 60,000
2018-05-09 Cline Darren S (EVP, Commercial) Sale 9,000 55.33 497,979
2018-05-09 Cline Darren S (EVP, Commercial) Option Ex 9,000 15.94 143,415
2018-05-09 Siegall Clay B (President and CEO) Sale 18,832 55.05 1,036,645
2018-05-09 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2018-05-08 Baker Julian (Director) Buy 126,399 54.02 6,828,326
2018-05-07 Baker Julian (Director) Buy 129,715 53.70 6,966,344
2018-05-04 Baker Julian (Director) Buy 204,537 52.68 10,775,622
2018-05-03 Cline Darren S (EVP, Commercial) Sale 4,000 53.81 215,240
2018-05-02 Baker Julian (Director) Buy 69,947 52.72 3,687,605
2018-05-01 Baker Julian (Director) Buy 306,917 51.54 15,819,422
2018-05-01 Baker Julian (Director) Option Ex 20,000 10.08 201,600
2018-04-30 Baker Julian (Director) Buy 623,136 51.06 31,817,947
2018-04-09 Siegall Clay B (President and CEO) Sale 18,832 50.52 951,392
2018-04-09 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2018-03-20 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 31,039 16.04 497,958
2018-03-15 Himes Vaughn B (See Remarks) Sale 5,000 58.48 292,375
2018-03-15 Himes Vaughn B (See Remarks) Option Ex 5,000 12.00 60,000
2018-03-09 Siegall Clay B (President and CEO) Sale 18,832 57.47 1,082,180
2018-03-09 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2018-03-05 Drachman Jonathan G (CMO & EVP, R & D) Sale 10,457 52.91 553,279
2018-03-05 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 10,457 8.96 93,694
2018-02-13 Welch Daniel G (Director) Option Ex 16,881 9.23 155,811
2018-02-09 Siegall Clay B (President and CEO) Sale 18,832 50.18 944,933
2018-02-09 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2018-02-01 Baker Felix (Director) Buy 3,846,153 52.00 199,999,956
2018-01-11 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 19,416 11.30 219,497
2018-01-11 Siegall Clay B (President and CEO) Sale 18,832 52.12 981,523
2018-01-11 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2017-12-11 Siegall Clay B (President and CEO) Sale 18,832 55.06 1,036,946
2017-12-11 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2017-12-04 Dobmeier Eric (Chief Operating Officer) Sale 3,729 58.75 219,093
2017-12-04 Dobmeier Eric (Chief Operating Officer) Option Ex 6,165 33.57 206,959
2017-11-30 Himes Vaughn B (Chief Technical Officer) Sale 10,000 60.19 601,870
2017-11-30 Himes Vaughn B (Chief Technical Officer) Option Ex 10,000 12.11 121,070
2017-11-17 Dobmeier Eric (Chief Operating Officer) Sale 10,000 59.12 591,250
2017-11-17 Dobmeier Eric (Chief Operating Officer) Option Ex 10,000 26.10 261,000
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seagen Inc. (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.